← Study Library
In vitro · 2013
Preclinicalcounts toward this tierEvidence for a common mechanism of SIRT1 regulation by allosteric activators
Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T · Science
Preclinicalcounts toward this tier
The counter-argument: hydrophobic motifs in natural SIRT1 substrates such as PGC-1alpha and FOXO3a permit activation without any fluorophore, and a single residue (Glu230) was required for activation by every activator class tested. In cells carrying activation-defective SIRT1, the metabolic effects of these compounds were abolished.
- Population
- Purified SIRT1, primary cells reconstituted with mutant SIRT1
- Intervention
- Resveratrol and other sirtuin-activating compounds against native substrates
- Comparator
- Activation-defective SIRT1 (E230K)
- Limitations
- In vitro and primary cells; several authors were affiliated with Sirtris/GSK, the company built on sirtuin-activating compounds, which is disclosed and belongs in any reading of the exchange.
Cited by
2 entries reference this study
- NMN / NAD+ precursorsPRECL.
Supplements → Vitamins & cofactors
- ResveratrolNOT SUPP.
Supplements → Anti-inflammatories